Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-28

FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for enoxaparin sodium from Gland Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin sodium (Enoxaparin sodium)

Snippet

SUPPL AP for ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)